https://orcid.org/0000-0003-3624-3509
References
- Murphy SL, Mathews TJ, Martin JA, et al. Annual summary of vital statistics: 2013–2014. Pediatrics. 2017;139(6):e20163239.
- Rudan I, Chan KY, Zhang JS, et al. Causes of deaths in children younger than 5 years in China in 2008. Lancet. 2010;375(9720):1083–1089.
- Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
- Gravett MG, Novy MJ, Rosenfeld RG, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004;292(4):462–469.
- Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18(4):757–789.
- Romero R, Garite TJ. Twenty percent of very preterm neonates (23–32 weeks of gestation) are born with bacteremia caused by genital Mycoplasmas. Am J Obstet Gynecol. 2008;198(1):1–3.
- Suzuki Y, Horie K, Yada Y, et al. Vaginal Ureaplasma species increase chorioamnionitis in very preterm infants with preterm premature rupture of the membranes at <28 weeks of gestation. Eur J Clin Microbiol Infect Dis. 2018;37(12):2371–2380.
- Gerber S, Vial Y, Hohlfeld P, et al. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis. 2003;187(3):518–521.
- Waites KB, Schelonka RL, Xiao L, et al. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonat Med. 2009;14(4):190–199.
- ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 475: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2011;117(2 Pt 1):422–424.
- Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am J Obstet Gynecol. 1994;170(5):1345–1351.
- Blanc WA. Pathology of the placenta, membranes, and umbilical cord in bacterial, fungal, and viral infections in man. Monogr Pathol. 1981;22(22):67–132.
- Breugelmans M, Vancutsem E, Naessens A, et al. Association of abnormal vaginal flora and Ureaplasma species as risk factors for preterm birth: a cohort study. Acta Obstet Gynecol Scand. 2010;89(2):256–260.
- Koucký M, Malíčková K, Cindrová-Davies T, et al. Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy – results of a pilot study. J Reprod Immunol. 2016;116:35–41.
- Kwak DW, Cho HY, Kwon JY, et al. Usefulness of maternal serum C-reactive protein with vaginal Ureaplasma urealyticum as a marker for prediction of imminent preterm delivery and chorioamnionitis in patients with preterm labor or preterm premature rupture of membranes. J Perinat Med. 2015;43(4):409–415.
- Lee SE, Romero R, Kim EC, et al. A high Nugent score but not a positive culture for genital mycoplasmas is a risk factor for spontaneous preterm birth. J Matern Fetal Neonat Med. 2009;22(3):212–217.
- Donders GGG, Ruban K, Bellen G, et al. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen. J Perinat Med. 2017;45(5):505–515.
- Ireland DJ, Keelan JA. The maternal serological response to intrauterine Ureaplasma sp. Infection and prediction of risk of pre-term birth. Front Immunol. 2014;5:624.
- Horowitz S, Mazor M, Horowitz J, et al. Antibodies as reagents for identification of intraamniotic infection with Ureaplasma urealyticum during pregnancy. Isr J Med Sci. 1994;30(5-6):450–454.
- Vouga M, Greub G, Prod’hom G, et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect. 2014;20(10):1074–1079.
- Raynes-Greenow CH, Roberts CL, Bell JC, et al. Antibiotics for Ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev. 2004;1:CD003767.
- Eschenbach DA, Nugent RP, Rao AV, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1991;164(3):734–742.